Portfolio Lab

Medline Inc.

  • Stock
  • Ticker MDLN
  • ISIN US58507V1070
  • Nasdaq

Health care · Medical technology · USA

$37.04 −2.11%
Close of 20 Nov 2026
Open in backtest

Medline Inc. has only been trading since 17 Dec 2025. This page shows what the short price history tells, measured from the closing price on the first day with prices. Annualized return, volatility and calendar-year returns follow once a year of prices is available. As of 20 Nov 2026.

Performance since the first day with prices

MDLNGlobal equities (VT)

$10,000 grew to $9,034. Global equities (VT): $10,362.

Daily values from the closing price on the first day with prices, not from an offer price. Excluding taxes and account costs. Dashed: Global equities (VT) for comparison.

First day with prices
17 Dec 2025
Trading days with prices
234
Since the first day with prices
−9.7%
Largest decline
−36.7%
Global equities over the same period
+3.6%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end03/202506/202509/202512/202512/202503/202606/202609/2026
Income statement
Revenue6,6446,8867,115–7,7877,3527,6857,856
Gross profit1,8241,9051,875–1,9141,8412,2151,925
Operating income571642574–425422395500
EBITDA818892827–686676651759
Net income319329318187193239139318
Earnings per share–––––0.160.070.22
Balance sheet
Total assets––––38,48439,01439,35040,178
Liabilities––––19,19819,66520,27320,792
Equity––––10,73711,27211,57211,801
Cash840584955–1,9392,2362,3272,321
Long-term debt––––12,48412,49512,54812,551
Cash flow
Operating cash flow682197636–2294127151,025
Capital expenditure-98-110-101–-138-96-111-141
Free cash flow58487535–91316604884

Value it:DCF calculatorMultiples calculator

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
4 Nov 2026$0.22
5 Aug 2026$0.07
6 May 2026$0.16
25 Feb 2026–

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€44bn
Market cap in trading currency
$48.8bn
Enterprise value
$57.7bn
P/E
–
P/S
1.59
P/B
4.13
EV/Sales
1.88
EV/EBITDA
20.8
Earnings yield
–
FCF yield
3.9%

Results (last four quarters)

Revenue
$30.7bn
Gross profit
$7.90bn
EBITDA
$2.77bn
Net income
$889m
Earnings per share
–
Revenue per share
$23.31
Revenue growth
+10.4%
Earnings growth
0.0%

Profitability

Gross margin
25.7%
Operating margin
5.7%
Net margin
2.9%
Return on equity
7.5%
Return on assets
2.2%

Balance sheet and cash flow

Cash
$3.61bn
Cash per share
$2.74
Financial debt
$12.6bn
Debt/equity %
107
Current ratio
4.04
Book value per share
$8.96
Operating cash flow
$2.38bn
Free cash flow
$1.90bn

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
–
Ex-dividend date
–

Shares and trading

Shares outstanding
1.32bn
Volume
9.29m
Avg. volume 3 months
8.91m
Relative volume
1.0

Price and technicals

Price
$37.04
1 day
−2.1%
52-week high
$49.99
52-week low
$31.64
Distance to 52-week high
−25.9%
Distance to 52-week low
+17.1%
Distance to 50-day line
+3.8%
Distance to 200-day line
−5.5%
RSI (14)
49
Volatility 1M
73.1%

Performance

1 week
−6.2%
1 month
+6.2%
3 months
+6.7%
6 months
+0.1%
YTD
−11.8%
1 year
–

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
26 Sep 2026

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Medline Inc. (MDLN): Return and risk | Portfolio Lab